Kagami/SDS Project
Phase 2
- Conditions
- Gastrointestinal Endoscopic Tests (Including Endoscopic Polypectomy)
- Registration Number
- JPRN-jRCT2080221299
- Lead Sponsor
- AstraZeneca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Be undergoing a non-emergent esophagogastroduodenoscopy (EGD) or colonoscopy.
Exclusion Criteria
- American Society of Anesthesiologists (ASA) grade III, IV V and VI
- Baseline oxygen saturation<90% (room air)
- Body Mass Index (BMI) >=35
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method